Anticoagulant drug developer Cardrenal Therapeutics files for $10M IPO business September 23, 2022 [ad_1] designer491 Anticoagulant drug developer Cardrenal Therapeutics (CVKD) has filed for a proposed $10M initial public offering. Cardrenal said in…
